2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer AgentMasako Yokoo, Shinya Kimura|PLoS ONE|2015Cited by 77
The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effectsHidekazu Itamura, Shinya Kimura|JCI Insight|2016Cited by 26
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphomaKensuke Kojima, Shinya Kimura|Oncotarget|2016Cited by 13
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cellsTatsuro Watanabe, Shinya Kimura|Blood Advances|2024Cited by 9
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell ProliferationKazunori Kawasoe, Shinya Kimura|Cancers|2023Cited by 3